Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

[Radical prostatectomy for high risk localized prostate cancer. Prognosis and study of influential variables].

Rincón Mayans A, Zudaire B, Brugarolas J, Rioja J, Zudaire J, Rosell D, Robles JE, Berian JM, Pascual I.

An Sist Sanit Navar. 2012 Jan-Apr;35(1):9-18. Spanish.

2.

[Gleason score 8-10 prostatic adenocarcinoma: prognostic influence in the biochemical progression free survival].

Rioja Zuazu J, Zudaire Berbera JJ, Rincón Mayans A, Rosell Costa D, Robles Garcia JE, Berian Polo JM.

Actas Urol Esp. 2008 Sep;32(8):792-8. Spanish.

PMID:
19013977
3.

Radical prostatectomy. Prognostic value of positive surgical margins in pT2 patients.

Algarra R, Zudaire J, Tienza A, Velis JM, Merino I, Barba J, Tolosa E, Rincón A, Robles JE, Pascual I.

Arch Esp Urol. 2013 Oct;66(8):796-806. English, Spanish.

PMID:
24136483
4.

[Radical prostatectomy in clinically localized prostatic adenocarcinoma. Study of patients with positive margins and their impact on survival free from biochemical progression].

Zudaire Bergera JJ, Martín-Marquina Aspiunza A, Sánchez Zalabardo D, Arocena García-Tapia J, Sanz Pérez G, Diez Caballero F, Rosell Costa D, Robles García JE, Berián Polo JM.

Actas Urol Esp. 1999 Nov-Dec;23(10):835-42. Spanish.

PMID:
10670124
5.

[Radical prostatectomy in clinically localized prostatic adenocarcinoma. Factors influencing biochemical progression free survival].

Zudaire Bergera JJ, Martín-Marquina Aspiunza A, Sánchez Zalabardo D, Arocena García-Tapia J, Sanz Pérez G, Díez Caballero F, Rosell Costa D, Robles García JE, Berián Polo JM.

Actas Urol Esp. 1999 Apr;23(4):333-41. Spanish.

PMID:
10394654
6.

Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.

Kupelian PA, Katcher J, Levin HS, Klein EA.

Int J Radiat Oncol Biol Phys. 1997 Mar 15;37(5):1043-52.

PMID:
9169811
7.

Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.

Ploussard G, Agamy MA, Alenda O, Allory Y, Mouracade P, Vordos D, Hoznek A, Abbou CC, de la Taille A, Salomon L.

BJU Int. 2011 Jun;107(11):1748-54. doi: 10.1111/j.1464-410X.2010.09728.x. Epub 2010 Sep 30.

8.

Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.

Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI, Walsh PC.

J Urol. 2003 Feb;169(2):517-23.

PMID:
12544300
9.

Radical prostatectomy. Detailed surgical margins. Prognostic value of multifocal involvement in pT2 (+).

Algarra R, Merino I, Hevia M, Velis JM, Tienza A, Zudaire J, Rosell D, Robles JE, Diez-Caballero F, Pascual I.

Arch Esp Urol. 2014 Apr;67(3):249-58. English, Spanish.

PMID:
24840590
10.

[Radical prostatectomy in stage pT3C stage prostatic adenocarcinoma].

Zudaire Bergera JJ, López Ferrándiz J, Sánchez Zalabardo D, Arocena García-Tapia J, Sanz Pérez G, Díez Caballero F, Rosell Costa D, Robles García JE, Berián Polo JM.

Actas Urol Esp. 2000 Jun;24(6):468-74. Spanish.

PMID:
11011429
11.

Prognostic value of seminal vesicle involvement due to prostate cancer in radical prostatectomy specimens.

Algarra R, Barba J, Merino I, Tienza A, Tolosa E, Robles JE, Zudaire J.

Actas Urol Esp. 2015 Apr;39(3):144-53. doi: 10.1016/j.acuro.2014.05.009. Epub 2014 Jul 2. English, Spanish.

PMID:
24996780
12.

Radical prostatectomy in very high-risk localized prostate cancer: long-term outcomes and outcome predictors.

Joniau S, Hsu CY, Gontero P, Spahn M, Van Poppel H.

Scand J Urol Nephrol. 2012 Jun;46(3):164-71. doi: 10.3109/00365599.2011.637956. Epub 2012 Feb 27.

PMID:
22364377
13.

Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics.

Graefen M, Noldus J, Pichlmeier U, Haese A, Hammerer P, Fernandez S, Conrad S, Henke R, Huland E, Huland H.

Eur Urol. 1999;36(1):21-30.

PMID:
10364651
14.

[Risk factors for biochemical recurrence after radical prostatectomy in patients with clinically localized prostate cancer. Implications of adjuvant treatment].

Fagundo EV, Amo FH, López EL, Sánchez JP, Jiménez Gdel P, Chamizo JA, Cordero JM, Fernández ME, Fernández CH.

Arch Esp Urol. 2012 Jan-Feb;65(1):158-65. Spanish.

PMID:
22318186
15.

Role of radical prostatectomy in patients with prostate cancer of high Gleason score.

Tefilli MV, Gheiler EL, Tiguert R, Banerjee M, Sakr W, Grignon D, Wood DP Jr, Pontes JE.

Prostate. 1999 Apr 1;39(1):60-6.

PMID:
10221268
16.
17.

Predicting recurrence after radical prostatectomy for patients with high risk prostate cancer.

Grossfeld GD, Latini DM, Lubeck DP, Mehta SS, Carroll PR.

J Urol. 2003 Jan;169(1):157-63.

PMID:
12478126
18.
19.

Optimizing D'Amico risk groups in radical prostatectomy through the addition of magnetic resonance imaging data.

Algarra R, Zudaire B, Tienza A, Velis JM, Rincón A, Pascual I, Zudaire J.

Actas Urol Esp. 2014 Nov;38(9):594-9. doi: 10.1016/j.acuro.2014.03.003. Epub 2014 May 3. English, Spanish.

PMID:
24791621
20.

Mayo Clinic validation of the D'amico risk group classification for predicting survival following radical prostatectomy.

Boorjian SA, Karnes RJ, Rangel LJ, Bergstralh EJ, Blute ML.

J Urol. 2008 Apr;179(4):1354-60; discussion 1360-1. doi: 10.1016/j.juro.2007.11.061. Epub 2008 Mar 4.

PMID:
18289596
Items per page

Supplemental Content

Write to the Help Desk